VAN WIJMEERSCH, Bart

Email Alert RSS Feed

Profile

Full Name

VAN WIJMEERSCH, Bart

Email

bart.vanwijmeersch@uhasselt.be

Loading... 5 0 5 0 false

Loading... 6 0 5 0 false

Publications

@UHasselt

All

Author

Date issued

Type

Internal UHasselt

23 VAN WIJMEERSCH, Bart
2 JACOBS, Andre

Refined By:

Author: Comi, G.

Results 21-23 of 23 (Search time: 0.002 seconds).

1
2

Bibtex Excel CSV FWO

		Issue Date	Title	Contributor(s)	Type	Cat.
	21	2017	Comparative clinical efficacy of alemtuzumab and ocrelizumab in patients with relapsing-remitting multiple sclerosis: Number needed to treat analyses	Comi, G.; Boster, A.; Alroughani, R.; Berkovich, R.; Izquierdo, G.; Kantor, D.; Laganke, C.; Limmroth, V.; Macdonell, R.; Moreau, T.; Sharrack, B.; Wiendl, H.; VAN WIJMEERSCH, Bart; Margolin, D. H.; Thangavelu, K.; Melanson, M.; Freedman, M. S.	Journal Contribution	M
	22	2016	Design of two phase III open-label trials evaluating ocrelizumab in patients with relapsing-remitting multiple sclerosis and suboptimal response to disease-modifying treatment	Bermel, R.; Comi, G.; Eralinna, J. -P.; Leist, T. P.; Nicholas, R.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Wiendl, H.; Bernasconi, C.; Buffels, R.; Csoboth, C.; Han, J.; Musch, B.; Vermersch, P.	Journal Contribution	M
	23	2016	Durable reduction in MRI disease activity with alemtuzumab in treatment-naive patients with active relapsing-remitting multiple sclerosis: 6-year follow-up of the CARE-MS I study	Arnold, D. L.; Barnett, M.; Comi, G.; Giovannoni, G.; Pelletier, D.; Rovira, A.; Schippling, S.; VAN WIJMEERSCH, Bart; Margolin, D. H.; Thangavelu, K.; Traboulsee, A.	Journal Contribution	M

1
2